ROSEN, STILLED INVESTOR COUNSEL, Encourages RTX Corporation f/k/a Raytheon Technologies Corporation Investors to Inquire About Securities Class Action Investigation – RTX
02 août 2023 11h48 HE
|
The Rosen Law Firm PA
NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of RTX...
Bragar Eagel & Squire, P.C. Is Investigating Veradigm and RTX and Encourages Investors to Contact the Firm
31 juil. 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Veradigm, Inc. (NASDAQ:...
RTX CORP. INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at RTX Corporation
26 juil. 2023 18h49 HE
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, July 26, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of RTX Corp. f/k/a Raytheon Technologies Corp. (“RTX”...
RTX Corporation Investigation Alert: Johnson Fistel, LLP Encourages Investors to Submit Their Information Below
25 juil. 2023 15h11 HE
|
Johnson Fistel, LLP
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP (www.JohnsonFistel.com) is investigating whether RTX Corporation ("RTX" or the “Company”) (NYSE: RTX),...
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
26 sept. 2022 09h00 HE
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OAK pain completed enrollment with last patient (n=120) dosedNo limiting toxicities have been encountered during the trial to date. Patients are now being monitored for...
RAYTHEON ALERT: Bragar Eagel & Squire, P.C. is Investigating Raytheon Technologies Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
17 déc. 2021 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Raytheon Technologies...
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
06 juil. 2021 14h34 HE
|
Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a single intra-articular administration without dose limiting toxicity (DLT) at any doses...
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Sequential Brands and Raytheon on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
22 janv. 2021 20h00 HE
|
Bragar Eagel & Squire
NEW YORK, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Sequential Brands...
FINAL DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds Raytheon Technologies Corporation f/k/a Raytheon Company Investors of Important December 29 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – RTX, RTN
24 déc. 2020 16h12 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Raytheon Technologies Corporation f/k/a Raytheon Company (NYSE:...
ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Raytheon Technologies Corporation f/k/a Raytheon Company Investors of Important Deadline in Securities Class Action First Filed by the Firm; Encourages Investors with Losses in Excess of $100K to Contact Firm – RTX, RTN
15 déc. 2020 16h08 HE
|
The Rosen Law Firm PA
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Raytheon Technologies Corporation f/k/a Raytheon Company (NYSE:...